Multiple sclerosis (MS) is a disorder characterized by inflammation and neuroaxonal degeneration that leads to irreversible disability.\[[@ref1]\] Optic neuritis (ON) in many cases is a presenting sign as it develops concurrently in many cases of MS.\[[@ref2]\] Optical coherence tomography (OCT) is an essential investigation to evaluate axonal/neuronal integrity and to assess disease progression in the afferent visual pathway.\[[@ref3]\] OCT is non-invasive, patient friendly, and highly reproducible, and OCT indices have been used as a marker of axonal loss and as an endpoint in clinical trials.\[[@ref4]\] High-resolution spectral domain-OCT (SD-OCT) techniques and computerized algorithms for image analysis have further improved the segmentation and measurement of specific retinal layers such as the ganglion cell layer (GCL) and the inner plexiform layer (IPL). These retinal layers have been studied to understand the pathophysiology of MS.\[[@ref5]\]

Patients with MS are usually referred to an ophthalmologist following the onset of ON. OCT imaging of these patients allows evaluation of the extent of damage due to ON and monitoring the progress of ON.\[[@ref6]\] The prevalence of MS is rising in the Gulf countries. It is linked to vitamin D deficiency and high consanguinity in the region.\[[@ref7]\] Females have higher rate of MS and ON compared to males in the Arab population.\[[@ref8]\] To the best of our knowledge, a study of the changes in thickness of different retinal layers in Arab patients with MS without ON has not been published.

This study evaluated the thickness of different macular parameters and peripapillary retinal nerve fiber layer (RNFL) at different quadrants in recently diagnosed MS patients without ON and compared these measurements to those of healthy individuals to determine their role in early detection of axonal damage in MS patients.

Methods {#sec1-2}
=======

This cross-sectional study was performed between June 2014 and June 2015. The ethics committee of our institute approved this study. Patients diagnosed with MS by a neurologist but without any ocular symptoms of MS were included in the present study (MS group). A patient with a history of any retinal disease or ON, including glaucoma, refractive error of 4.00D or greater, previous eye surgery, or those showing OCT scans with low signal strength were excluded. Healthy volunteers with best-corrected visual acuity (BCVA) of 1.0 and without any ocular disease were included as a comparison group (control group). All subjects signed a written informed consent to participate in the study.

We assumed that RNFL thickness at the macula in eyes of healthy Arab individuals was 35 ± 4 μ.\[[@ref9]\] In eyes with MS, the RNFL was assumed to be 30 ± 12 μ. To achieve 95% confidence interval (CI), 90% power of the study with 1:2 ratio of two groups of at least 37 eyes were required in the MS group and 77 eyes in the control group.

Three ophthalmologists, one neurologist, and one optometrist were the field investigators. Data were collected on age and gender in both groups. Patients underwent a detailed neurological examination by a neurologist. Early stage MS was confirmed based on the duration of the disease, medications, clinical findings, functional, radiological, laboratory, and electrophysiological examinations.

All subjects underwent a comprehensive ophthalmic examination including measurement of BCVA (Snellen) at 6-m distance with a projection chart, anterior segment assessment with slit-lamp bio-microscopy (HAAG-STREIT AG, Koeniz, Switzerland), Goldmann applanation tonometry, and pupillary light reflex were tested using a well-focused torch light beam.\[[@ref10]\]

The posterior segment and peripheral retina were examined using binocular indirect ophthalmoscopy (Keeler, UK) and a +20D Volk lens. The optic disc and macula were also assessed using slit lamp and +90D Volk lens (Volk Optical Inv., Mentor, OH, USA).

After pupillary dilatation, the retinal thickness of each eye was measured using three-dimensional (3D) OCT-2000 (Topcon Corporation, Tokyo, Japan). A 3D disc scan protocol was used which allowed analysis of a 6 mm × 6 mm area centered on the optic disc with a scan density of 512 vertical × 128 horizontal scans. (1) The mean and standard deviations of the peripapillary RNFL thickness were calculated in four quadrants and clock-hour sectors at a circular distance of 3.4 mm in diameter from the optic disc. (2) Macular 3D V scan protocol was performed \[scanning of a 7 mm × 7 mm area centered on the fovea with a scan density of 512 (vertical) × 128 (horizontal) scans\]. The mean and standard deviations of the macular RNFL (mRNFL), GCL + IPL, and GCL + IPL + nerve fiber layer (NFL) (GCL++) thicknesses were calculated for the superior and inferior hemiretina. These measurements were obtained in one disc diameter inferiorly and superiorly to the fovea. The unit of measurement for retinal thickness was microns (μ).

Data were collected on a pretested data collection form and transferred to an Excel spreadsheet (Microsoft Corp., Redmond, WA, USA). The data were then transferred to a Statistical Package for Social Sciences spreadsheet (SPSS 23, IBM Corp., New York, NY, USA). For qualitative variables, we calculated frequencies and percentage proportions. For quantitative variables, we plotted histogram to study its distribution. If the data were normally distributed, the mean and standard deviations were calculated. To compare the quantitative data between groups, the difference of mean, its 95% CI, and two-sided *P* values were calculated. Variables that were statistically significant associated to MS were added to a regression model to study the interaction of different variables. The adjusted odds ratio, the 95% CI, and two-sided *P* values were calculated. A *P* value \<0.05 was considered statistically significant.

Results {#sec1-3}
=======

Thirty-two eyes were enrolled in the MS group and 74 eyes in the control group. All the subjects in the MS group were diagnosed within 1 year (median duration: 5 months) of the beginning of this study.

The demographic and clinical characteristics of both groups are compared in [Table 1](#T1){ref-type="table"}. The control group was significantly older than those with MS (*P* \< 0.01). Retinal layer thickness of both groups is presented in [Table 2](#T2){ref-type="table"}. The mean ganglion cell complex (GCL++) thickness in superior macular area in MS group and control group was 33.3 ± 7.8 μ and 37.9 ± 5.5 m, respectively. All macular parameters were significantly thinner in the MS group compared to the control group \[Figs. [1](#F1){ref-type="fig"}-[3](#F3){ref-type="fig"}\]. The RNFL thickness in the different quadrants did not differ between groups.

###### 

Profile of patients with and without multiple sclerosis (MS)

                            Parameter         MS patients (*n*=32)   No MS (*n*=74)   Validation                            
  ------------------------- ----------------- ---------------------- ---------------- ------------------------------ ------ ----------
  Gender                    Male              12                     37.5             40                             54.1   *P*=0.12
  Female                    20                63.5                   34               45.9                                  
  Eye involved              Right             16                     50               36                             48.6   *P*=0.9
  Left                      16                50                     38               51.4                                  
  Age                       Mean              32.7                   43.5             Diff of mean 10.8 *P*\<0.001          
  SDV                       7.7               10.9                                                                          
  BCVA                      Median            1.0                    1.0              M-W *P*=0.4                           
  25% quartile              1.0               1.0                                                                           
  RE Spherical equivalent   Median            −0.37                  −0.1             M-W *P*=0.14                          
  25% quartile              −0.63             −0.38                                                                         
  Pupil                     RRR               32                     \-               74                                    \-
  Lens                      Clear             32                     100              74                             100    \-
  Lens opacity              0                 0                      0                0                                     
  Optic nerve head          Normal            29                     90.6             74                             97.2   \-
                            Past neuropathy   3                      9.4              0                              2.8    

###### 

Retinal layer thickness in eyes of patient with MS and without MS

  OCT parameters of retinal layer thickness                                               Eye with MS (32)   Eye without MS (74)   Validation          
  --------------------------------------------------------------------------------------- ------------------ --------------------- ------------ ------ ---------
  Total macular retinal nerve fiber layer                                                 33.3               7.8                   37.9         5.5    0.04
  Superior macular retinal nerve fiber layer                                              32.2               8.0                   36.4         5.4    0.009
  Inferior macular retinal nerve fiber layer                                              34.3               7.9                   39.4         6.1    0.002
  Thickness of ganglion cell layer + inner plexiform layer                                64.3               8.4                   71.7         5.9    \<0.001
  Thickness of ganglion cell layer + inner plexiform layer superior                       64.7               8.1                   72.3         6.1    0.001
  Thickness of ganglion cell layer + inner plexiform layer superior inferior              64.1               8.9                   71.1         5.9    \<0.001
  Thickness of ganglion cell layer + inner plexiform layer + nerve fiber layer            97.7               14.9                  108.3        14.4   \<0.001
  Thickness of ganglion cell layer + inner plexiform layer + nerve fiber layer superior   96.8               14.7                  108.8        10.1   \<0.001
  Thickness of ganglion cell layer + inner plexiform layer + nerve fiber layer inferior   98.5               15.6                  110.3        10.0   \<0.001
  Total retinal nerve fiber layer thickness                                               101.8              13.9                  100.9        8.0    0.7
  Average retinal nerve fiber layer thickness in superior quadrant                        122.6              18.4                  118.2        11.9   0.2
  Average retinal nerve fiber layer thickness in nasal quadrant                           88.5               19.0                  81.8         13.1   0.08
  Average retinal nerve fiber layer thickness in inferior quadrant                        125.0              19.0                  127.7        13.4   0.5
  Average retinal nerve fiber layer thickness in temporal quadrant                        72.1               18.1                  75.6         9.9    0.3

![Multiple sclerosis patient 1: (a) Peripapillary retinal nerve fiber layer thickness. Disc circle (Dia. 3.4--1024 mm) \[spectral domain-optical coherence tomography (SD-OCT)\]. (b) Ganglion cell layer complex thickness at macula (OD). Macular 3D V scan protocol (SD-OCT). (c) Ganglion cell layer complex thickness at macula (OS). Macular 3D V scan protocol (SD-OCT)](IJO-67-648-g001){#F1}

![Multiple sclerosis patient 2: (a) Peripapillary retinal nerve fiber layer thickness. Disc circle (Dia. 3.4--1024 mm) \[spectral domain-optical coherence tomography (SD-OCT)\]. (b) Ganglion cell layer complex thickness at macula (OD). Macular 3D V scan protocol (SD-OCT). (c) Ganglion cell layer complex thickness at macula (OS). Macular 3D V scan protocol (SD-OCT)](IJO-67-648-g002){#F2}

![Control 1: (a) Peripapillary retinal nerve fiber layer thickness. Disc circle (Dia. 3.4--1024 mm) \[spectral domain-optical coherence tomography (SD-OCT)\]. (b) Ganglion cell layer complex thickness at macula (OD). Macular 3D V scan protocol (SD-OCT). (c) Ganglion cell layer complex thickness at macula (OS). Macular 3D V scan protocol (SD-OCT)](IJO-67-648-g003){#F3}

Binominal regression analysis suggested that in spite of controlling for the age, the macular thickness parameters were significantly thinner in eyes of the MS group compared to the control group.

Discussion {#sec1-4}
==========

The current study found that the macular parameters of retinal thickness in eyes of subjects with MS without ON were thinner compared to age-matched healthy individuals. Refractive error is a known factor that influences RNFL thickness. However, there was no statistical difference between groups in refractive error. The RNFL in the four quadrants did not significantly differ in eyes with early MS without ON compared to healthy eyes.

All the subjects with MS in the current study did not exhibit any ophthalmic manifestations of the disease. The MS group had normal vision and no optic nerve head changes. Based on these observations, we conclude that eyes of the subjects with MS did not have ON which is a common manifestation of MS.\[[@ref11][@ref12]\]

Macular retinal thickness is influenced by late stage glaucoma.\[[@ref13]\] In a previous study, we reported that the retinal thickness was significantly thinner among Saudi glaucoma patients compared to normal healthy patients.\[[@ref14]\] Due to exclusion of all cases with known ocular pathology including glaucoma, the present study is less likely to have thinner macular parameter thickness due to other pathology such as glaucoma.

Refractive error did not significantly differ in the MS group compared to the control group in the present study. None of the subjects in the current study were high myopes. High myopia is associated with macular changes, which can be easily identified by OCT.\[[@ref15]\] High myopia constituted 16.3% of total myopia in a young cohort from Oman, which is a neighboring Gulf country.\[[@ref16]\] Therefore, the presence of high myopia should be noted before reviewing the thinning of macular parameters by OCT and association with MS.

In our study, cases of age-related macular degeneration (AMD) were excluded. Additionally, the MS group was relatively young and less likely to have occult/early AMD changes. However, as a precaution for comparing the retinal layer thickness changes between groups, we ruled out the confounding effect of age. The retinal and vitreous changes in the elderly population have been studied and suggest that even in healthy eyes the macula and retinal layers show degenerative changes.\[[@ref17][@ref18]\] The advent of OCT angiography had allowed the study of thinning of the macula in pathology such as AMD.\[[@ref19][@ref20]\] These studies have found differential effects between retinal layers in AMD.\[[@ref19][@ref20]\]

Thinning of the macular parameters has been postulated to be due to axonal degeneration in MS.\[[@ref21]\] In other neural degenerative conditions of the brain such as Alzheimer\'s, thinning of retinal layer has been documented.^\[22--24\]^ The death of neurons of central nervous system and their axons in the eye seems to be a common phenomenon in all these conditions including MS.

In the current study, segmental OCT analysis of retinal layers at the macula showed that the mean total GCL++ thickness (the thickness of GCL + IPL + nerve fiber layer) in the superior macula is the most affected. Longitudinal studies are recommended to confirm the role of this parameter in predicting early MS.

In the current study, the difference in the RNFL in different retinal regions other than the macula was not significant between groups. This is in contrast to changes in the eyes of MS patients with and without ON.\[[@ref25][@ref26]\] Patients in the MS group in the current study was in early stage of disease, which may account for the difference in outcomes between studies.

There are some limitations to the current study. In a cross-sectional study, whether the diagnosis of MS preceded macular thinning documented by OCT remains uncertain. Thus, a casual association cannot be established. Longitudinal studies to document changes in macular thickness over time in MS patients are recommended.

Conclusion {#sec1-5}
==========

GCL complex thickness at macula measured by high-resolution SD-OCT in our study was significantly thinner in eyes of patient with recently diagnosed MS and without ON. SD-OCT could be a useful tool for a detailed work-up in a case of MS even if patient does not have eye symptoms.
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